Gregg L Semenza
President at The Johns Hopkins University School of Medicine
Profile
Gregg L Semenza is the Director at the Institute For Cell Engineering.
He is also a Professor of Genetic Medicine at The Johns Hopkins University School of Medicine since 1990.
Additionally, he is a Venture Partner at Catalio Capital Management LP and an Advisor at Medical Excellence Capital LLC.
Semenza holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Harvard College.
Gregg L Semenza active positions
Companies | Position | Start |
---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Consultant / Advisor | - |
The Johns Hopkins University School of Medicine | President | 1989-12-31 |
Institute For Cell Engineering | Director/Board Member | - |
Training of Gregg L Semenza
Harvard College | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Finance |
Institute For Cell Engineering |
- Stock Market
- Insiders
- Gregg L Semenza